Stem Cell Therapeutics Corp., of Calgary, Alberta, said it grossed $2 million by selling about 18.18 million units, consisting of one common share and a warrant for one-half of a common share, at 11 cents per unit. Each warrant can be exercised within three years at a price of 16 cents.